Ablating CAR and Integrin Binding in Adenovirus Vectors Reduces Nontarget Organ Transduction and Permits Sustained Bloodstream Persistence Following Intraperitoneal Administration
Open Access
- 29 February 2004
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 9 (2) , 218-230
- https://doi.org/10.1016/j.ymthe.2003.10.010
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomasGene Therapy, 2002
- Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 statusGene Therapy, 2000
- Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouseCancer Gene Therapy, 1999
- Comparison of Long-term Survival of Cytomegalovirus Promoter versus Rous Sarcoma Virus Promoter-Driven Thymidine Kinase Gene Therapy in Nude Mice Bearing Human Ovarian CancerHybridoma, 1999
- A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cellsEuropean Journal Of Cancer, 1998
- The effects of the adenovirus-mediated wild-type p53 delivery in human epithelial ovarian cancer cell linein vitroandin vivoInternational Journal of Gynecologic Cancer, 1998
- A Phase I Study of Recombinant Adenovirus Vector-Mediated Intraperitoneal Delivery of Herpes Simplex Virus Thymidine Kinase (HSV-TK) Gene and Intravenous Ganciclovir for Previously Treated Ovarian and Extraovarian Cancer Patients. University of Alabama Comprehensive Cancer Center, Birmingham, ALHuman Gene Therapy, 1997
- A Phase I Study of Recombinant Adenovirus Vector-Mediated Delivery of an Anti-erbB-2 Single-Chain (sFv) Antibody Gene for Previously Treated Ovarian and Extraovarian Cancer Patients. University of Alabama at Birmingham, Birmingham, AlabamaHuman Gene Therapy, 1997
- Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinomaJournal of Molecular Medicine, 1996
- Targeted tumor killing via an intracellular antibody against erbB-2.Journal of Clinical Investigation, 1995